It is a class of bispecific T cell engagers (BiTEs) that target the CD3 cell surface antigen on T lymphocytes and the CD19 locus on (malignant) B lymphocytes (54), enabling T cell trafficking to tumor cells And showed strong tumor killing ability. The gene discussed is CD19; the disease is neoplasm.